Postbiotics

Akkermansia Muciniphila for Depression: Lipid Pathway Links Gut, Liver & Brain

Depression is far more than a psychological issue — it is a systemic metabolic disorder connecting gut, liver, and brain. A landmark 2026 study published in Frontiers in Pharmacology (PMID: 41993570) confirms that Akkermansia muciniphila alleviates depression by activating a critical glycerophospholipid metabolism pathway that synchronously repairs the gut, liver, and brain. This research uncovers […]

Akkermansia Muciniphila for Depression: Lipid Pathway Links Gut, Liver & Brain Read Post »

2026 New Clinical Evidence: Pasteurized Akkermansia Muciniphila Mucᵀ for Sustainable Weight Loss Maintenance & Metabolic Health

Akkermansia muciniphila weight loss maintenance is validated by the latest 2026 Nature Medicine randomized controlled trial. Published May 13, 2026, a groundbreaking randomized controlled trial in Nature Medicine delivers the latest gold‑standard human clinical proof that pasteurized Akkermansia muciniphila Mucᵀ is the most effective gut postbiotic for long‑term weight loss maintenance and metabolic wellness. For

2026 New Clinical Evidence: Pasteurized Akkermansia Muciniphila Mucᵀ for Sustainable Weight Loss Maintenance & Metabolic Health Read Post »

Beyond Probiotics: Postbiotics Are Shaping the Next Generation of Functional Nutrition

Postbiotics: From Emerging Science to Practical Innovation Beyond Probiotics: Postbiotics Are Shaping the Next Generation of Functional Nutrition — Insights from a recent Food Frontiers review In recent years, the gut health and functional food sectors have witnessed a paradigm shift with the rapid rise of postbiotics. A landmark review published in Food Frontiers has

Beyond Probiotics: Postbiotics Are Shaping the Next Generation of Functional Nutrition Read Post »

April 2026 Nature Study | Amuc_1098 From Akkermansia Muciniphila Supports Pancreatic & Gut Health

April 2026 Nature Study | Amuc_1098 From Akkermansia Muciniphila Supports Pancreatic & Gut Health Published Date: April 19, 2026 A brand-new research paper released on April 19, 2026, in Nature Communications reveals remarkable scientific evidence of Amuc_1098 membrane protein from Akkermansia Muciniphila, highlighting its multi-pathway benefits for gut homeostasis, inflammatory balance and pancreatic health maintenance.

April 2026 Nature Study | Amuc_1098 From Akkermansia Muciniphila Supports Pancreatic & Gut Health Read Post »

Akkermansia muciniphila Improves Alzheimer’s Disease via the Gut-Brain Axis

Fudan Team’s New Discovery: Akkermansia muciniphila Improves Alzheimer’s Disease via the Gut-Brain Axis In recent days, a research team led by Professor Liang Chunmin from the School of Basic Medical Sciences, Fudan University, in collaboration with multiple research institutions, has published a groundbreaking study in the Q1 journal Alzheimer’s Research & Therapy. The core finding:

Akkermansia muciniphila Improves Alzheimer’s Disease via the Gut-Brain Axis Read Post »

Probiotics, Prebiotics, Synbiotics, and Postbiotics: What’s the Difference?

Probiotics, Prebiotics, Synbiotics & Postbiotics: Key Differences A One-Sentence Guide to Understanding Them All Understanding these four concepts is essential for anyone involved in functional foods, dietary supplements, or gut health formulations. Let’s break them down—clearly and practically. Probiotics: The Beneficial Bacteria That Do the Work Probiotics are live microorganisms that, when administered in adequate

Probiotics, Prebiotics, Synbiotics, and Postbiotics: What’s the Difference? Read Post »

China Probiotics 2026: Market Summary & Innovation Outlook

Probiotics — defined by the FAO/WHO as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host” — have become one of the most dynamic segments within China’s health and nutrition ecosystem. The intersection of rising health awareness, consumer sophistication, scientific advancements and diversified application scenarios has positioned probiotics as a cornerstone

China Probiotics 2026: Market Summary & Innovation Outlook Read Post »

Akkermansia muciniphila and EU Implementing Regulation 2022/168

Novel Food Authorization and Regulatory Context Introduction Akkermansia muciniphila — a mucin‑degrading bacterium originally isolated from the human gut — has attracted significant scientific and regulatory interest due to its potential effects on human metabolism and gut health. While research continues on its clinical benefits (see Nature, PubMed), a major milestone in the regulatory landscape

Akkermansia muciniphila and EU Implementing Regulation 2022/168 Read Post »

Consumer FAQs: Pasteurized Akkermansia muciniphila

1. What is pasteurized Akkermansia muciniphila? Answer:Akkermansia muciniphila is a naturally occurring gut bacterium linked to metabolic and gut health. The pasteurized form means the bacteria are heat-treated (non-live) but still retain beneficial bioactive components. This makes it safe, stable, and easy to include in supplements or foods. 2. How does pasteurized Akkermansia help with

Consumer FAQs: Pasteurized Akkermansia muciniphila Read Post »